Evidence map›Paper›PMID 37187497›Full record

ArticleJournal of hematology2023

Treatment and Response Evaluation Challenges in a Pregnant Woman With B-Cell Lymphoblastic Leukemia and Li-Fraumeni Syndrome.

Bjarte Skoe Erikstein, Aymen Bushra Ahmed, Rakel Brendsdal Forthun, Friedemann Leh, Bjørn Tore Gjertsen, Håkon Reikvam

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bjarte Skoe EriksteinDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
Aymen Bushra AhmedDepartment of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
Rakel Brendsdal ForthunSection for Tumor Genomics, Haukeland University Hospital, Bergen, Norway.
Friedemann LehDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Bjørn Tore GjertsenDepartment of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
Håkon ReikvamDepartment of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
Haukeland University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Li-Fraumeni syndrome (LFS) is a cancer predisposing syndrome caused by pathogenic germline

Indexed as

Anti-CD20Anti-CD22B-cell lymphoblastic leukemiaBispecific anti-CD19/anti-CD3Heritable TP53-related cancerImmunotherapyLi-Fraumeni syndromePregnancy

Identifiers

PMID37187497
PMCPMC10181328
OpenAlexW4376643484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.